Home Your basket
• Sinonasal malignant schwa...
   Price 5.50 €
• Partial hearing recovery ...
   Price 5.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Navigation in head and ne...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• Diagnostic value of fine-...
   Price 8.50 €
• Speech intelligibility in...
   Price 10.50 €
• The benefit of phoniatric...
   Price 8.50 €
• Post-operative complicati...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• A simple assessment of qu...
   Price 10.50 €
• Tumours of the accessory ...
   Price 10.50 €
• The uses of computer-assi...
   Price 10.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Combined transoral and su...
   Price 10.50 €
• The ultra-low resistance ...
   Price 5.50 €
• Complete branchial cleft ...
   Price 5.50 €
• Thyroid differenciated ca...
   Price 10.50 €
• Diagnosis management of W...
   Price 10.50 €
• Choanal atresia : a retro...
   Price 8.50 €
• Advantages of combined th...
   Price 10.50 €
• Partial allotransplantati...
   Price 10.50 €
• Pseudoaneurysm of the int...
   Price 5.50 €
• Role of positron emission...
   Price 15.00 €
• Treatment failures in ben...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• Predictive factors for re...
   Price 14.00 €

Total Order 266.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2014 o

RHINOLOGY

Polypose nasosinusienne associée à un déficit en sous-classes d'Immunoglobuline G : place de la substi­tu­tion en immunoglobulines polyvalentes


Authors : Nhung Tran Khai Hoan, Karmochkine M, Laccourreye O, Bonfils P. (Paris)

Ref. : Rev Laryngol Otol Rhinol. 2014;135,3:151-155.

Article published in french
Downloadable PDF document french



Summary : Purpose: To study the effect of the introduction of a substi­t­u­t­ion by intravenous Immunoglobulins (Ig IV) at patients with immunoglobulins G (IgG) subclasses deficiency and nasal polyposis. Material and methods: Prospective study concer­ning five patients with IgG subclasses deficiency and nasal polyposis treated by Ig IV. Rhinologic, otologic and pulmonary symptoms, exacerbations of nasal polyposis, chronic otitis and asthma as well as the number of antibiotics and corticoids treat­ments were counted during the Ig IV substitution. Objectives: To study the association between IgIV substitution and the number of exacerbations of nasal polyposis, chronic otitis, asthma and the number of antibiotics and corticoids treatments in patients with IgG subclasses deficiency and nasal polyposis. Results: Five patients with a IgG subclass deficiency and nasal polyposis were substituted. The number of antibiotics and corticoids cures increased at one patient and remained stable at four others. The number of sinus, ear and lung infec­tions as well as the global rhinologic score of symptoms and the endoscopic stage of the nasal polyposis remained stable. In the absence of efficiency of the treatment, this one was interrupted at the end of 6 months for patients n° 1 and n° 3, 24 months for patient n° 4 and 42 months for patient n° 5. Conclusion: The current study failed to highlight clinical improvement in patients wih IgG subclasses deficiency and nasal polyposis treated by Ig IV. A previous study had not allowed to find a link between IgG subclasses deficiency and severity of nasal polyposis, what seems to be confirmed by the absence of improvement brought during the substitution of this deficit in the current study.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE